SCHEMBL17593152

SCHEMBL17593152

NC1[C@H]2CN(c3ccc4c(c3)NCCc3c-4[nH]c(=O)c(C(=O)O)c3O)C[C@@H]12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14756999 1.00
Hydrochloric Acid SCHEMBL14745769 0.99
Hydrochloric Acid SCHEMBL14745767 0.99
SCHEMBL14745991 0.86 IP6K1 (0.36)
Hydrochloric Acid SCHEMBL18628244 0.85
SCHEMBL14756992 0.84 KDM4E (0.30)
SCHEMBL17593319 0.84 SLC16A3 (0.32)
SCHEMBL14757061 0.84 SLC16A3 (0.32)
SCHEMBL17593332 0.84 KDM4E (0.30)
SCHEMBL17593167 0.83 MAOA (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2750678-B1 ANTIBACTERIAL COMPOUNDS AND METHODS FOR USE PTC THERAPEUTICS INC (US) 2017-03-22 EP disclosed
WO-2016039938-A1 POLYCYCLIC 2-PYRIDINONE ANTIBACTERIAL COMPOUNDS PTC THERAPEUTICS, INC. (US) 2016-03-17 WO disclosed